# Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye

> **NCT00765804** · PHASE2 · COMPLETED · sponsor: **Eyegate Pharmaceuticals, Inc.** · enrollment: 89 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** EGP-437 with EyeGate® II System
- **DRUG:** Sodium citrate buffer solution with EyeGate® II System

## Key facts

- **NCT ID:** NCT00765804
- **Lead sponsor:** Eyegate Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2010-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765804, "Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00765804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*